Fredun Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
Fredun Pharmaceuticals has a total shareholder equity of ₹1.3B and total debt of ₹1.4B, which brings its debt-to-equity ratio to 104.8%. Its total assets and total liabilities are ₹3.6B and ₹2.2B respectively. Fredun Pharmaceuticals's EBIT is ₹412.6M making its interest coverage ratio 2.5. It has cash and short-term investments of ₹17.3M.
Key information
104.8%
Debt to equity ratio
₹1.37b
Debt
| Interest coverage ratio | 2.5x |
| Cash | ₹17.30m |
| Equity | ₹1.31b |
| Total liabilities | ₹2.25b |
| Total assets | ₹3.55b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 539730's short term assets (₹3.0B) exceed its short term liabilities (₹2.1B).
Long Term Liabilities: 539730's short term assets (₹3.0B) exceed its long term liabilities (₹173.5M).
Debt to Equity History and Analysis
Debt Level: 539730's net debt to equity ratio (103.5%) is considered high.
Reducing Debt: 539730's debt to equity ratio has increased from 70.3% to 104.8% over the past 5 years.
Debt Coverage: 539730's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 539730's interest payments on its debt are not well covered by EBIT (2.5x coverage).